Reuters
Published Jun 15, 2021 06:17PM ET
Updated Jun 15, 2021 06:30PM ET
By Patricia Zengerle and David Shepardson
WASHINGTON (Reuters) - A highly touted bill to boost the United States' ability to compete with Chinese technology could take weeks to get through Congress, as U.S. House of Representatives lawmakers planned to write their own legislation, which must then be combined with what was approved by the Senate this month.
House Democratic Majority Leader Steny Hoyer said House committees were working on their legislation, which he hoped would pass with support from Republicans as well as Democrats.
"I think the House committee - or committees - have views that they want to express," Hoyer told reporters. "... I don't think there's anything nefarious about it. I hope that we will move forward with a bill."
Once the House passes its bill, negotiators from both chambers would work out differences and agree on a final version in conference. The House and Senate would both have to pass that final measure before it could be sent to the White House for President Joe Biden to sign into law.
"Hopefully we can work that out so that the best of both bills will be available to us, so that we can ensure our competitive status vis-a-vis China in particular and also dealing with some of the nefarious things that China does to pursue unfair trade tactics with our country, including intellectual property theft," Hoyer said.
House Science Committee Chairwoman Eddie Bernice Johnson said on Tuesday she favored an approach based on the current capabilities of the National Science Foundation and Department of Energy, in contrast to the approach outlined in the Senate bill.
"If we are to remain the world leader in science and technology, we need to act now. But we shouldn't act rashly," Johnson said as the committee considered two bills that would be part of the House bill.
"Instead of trying to copy the efforts of our emerging competitors, we should be doubling down on the proven innovation engines we have at the National Science Foundation and the Department of Energy," she said.
The U.S. Senate on June 8 backed by a strong bipartisan 68-32 majority the "U.S. Innovation and Competition Act," or USICA, which authorizes about $190 billion for provisions to strengthen U.S. technology and research, and approved $54 billion to increase U.S. production and research into semiconductors and telecommunications equipment.
It was not immediately clear how the House bill might differ from the Senate's approach on semiconductors. A global shortage of chips that has slowed production in the automobile and tech industries has added fuel to calls for the United States to rely less on China.
China's parliament expressed "strong indignation and resolute opposition" to the Senate bill, which was praised in Washington as a rare example of bipartisan action by the deeply divided U.S. Congress.
Biden's fellow Democrats control both the House and Senate, but only by narrow margins. However, the desire for a hard line in dealings with Beijing is a rare bipartisan sentiment in the deeply divided Congress.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.